These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 12617772)
1. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response. Zhang ZJ; Yao ZJ; Zhang XB; Chen JF; Sun J; Yao H; Hou G; Zhang XB Acta Pharmacol Sin; 2003 Mar; 24(3):235-40. PubMed ID: 12617772 [TBL] [Abstract][Full Text] [Related]
2. [Association of antipsychotic agent-induced weight gain with a polymorphism of the promotor region of the 5-HT2C receptor gene]. Zhang Z; Zhang X; Yao Z; Chen J; Sun J; Yao H; Hou G; Zhang X; Reynolds GP Zhonghua Yi Xue Za Zhi; 2002 Aug; 82(16):1097-101. PubMed ID: 12425817 [TBL] [Abstract][Full Text] [Related]
3. [No association of -1438G/A polymorphism in promoter region of 5-HT2A receptor gene with antipsychotic agent-induced weight gain]. Mou XD; Zhang ZJ; Yao ZJ; Liu W; Zhang XR; Shi JB; Sun J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):575-6. PubMed ID: 16215954 [TBL] [Abstract][Full Text] [Related]
4. [Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain]. Zhang ZJ; Yao ZJ; Mou XD; Chen JF; Zhu RX; Liu W; Zhang XR; Sun J; Hou G Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2119-23. PubMed ID: 14720418 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response. Reynolds GP; Yao Z; Zhang X; Sun J; Zhang Z Eur Neuropsychopharmacol; 2005 Mar; 15(2):143-51. PubMed ID: 15695058 [TBL] [Abstract][Full Text] [Related]
6. [-2548G/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: a study of nuclear family-based association]. Mou XD; Zhang ZJ; Zhang XR; Shi JB; Sun J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):316-20. PubMed ID: 18460775 [TBL] [Abstract][Full Text] [Related]
7. -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment. Ryu S; Cho EY; Park T; Oh S; Jang WS; Kim SK; Lee D; Hong KS Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):673-7. PubMed ID: 17275977 [TBL] [Abstract][Full Text] [Related]
8. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain. Popp J; Leucht S; Heres S; Steimer W Pharmacogenomics J; 2009 Feb; 9(1):71-7. PubMed ID: 18332898 [TBL] [Abstract][Full Text] [Related]
9. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients. Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448 [TBL] [Abstract][Full Text] [Related]
10. Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients. Wu S; Xing Q; Gao R; Li X; Gu N; Feng G; He L Neurosci Lett; 2005 Mar; 376(1):1-4. PubMed ID: 15694263 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)]. Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575 [TBL] [Abstract][Full Text] [Related]
12. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. Müller DJ; Klempan TA; De Luca V; Sicard T; Volavka J; Czobor P; Sheitman BB; Lindenmayer JP; Citrome L; McEvoy JP; Lieberman JA; Honer WG; Kennedy JL Neurosci Lett; 2005 May; 379(2):81-9. PubMed ID: 15823421 [TBL] [Abstract][Full Text] [Related]
13. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia. Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638 [TBL] [Abstract][Full Text] [Related]
14. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes. Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584 [TBL] [Abstract][Full Text] [Related]
15. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment]. Koga M Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910 [TBL] [Abstract][Full Text] [Related]
16. Risperidone-related weight gain: genetic and nongenetic predictors. Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140 [TBL] [Abstract][Full Text] [Related]
17. Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia. Kaiser R; Tremblay PB; Klufmöller F; Roots I; Brockmöller J Mol Psychiatry; 2002; 7(7):695-705. PubMed ID: 12192613 [TBL] [Abstract][Full Text] [Related]
18. 5-HT2A receptor gene polymorphism and negative symptoms in first episode (drug-naive) Chinese Han nationality individuals with schizophrenia. Wang YH; Li WQ; Huang Z; Shi YZ; Wang XY; Huang JS; Zhou XH; Chen HX; Hao W Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):293-8. PubMed ID: 18460771 [TBL] [Abstract][Full Text] [Related]
19. [Association of HTR2C-759C/T and -697G/C polymorphisms with antipsychotic agent-induced weight gain]. Shao P; Zhao JP; Chen JD; Wu RR; He YQ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 33(4):312-5. PubMed ID: 18460774 [TBL] [Abstract][Full Text] [Related]
20. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]